Juanita L Merchant Selected Research

Gastrins

1/2022	Gastrin: From Physiology to Gastrointestinal Malignancies.
1/2021	Interleukin-1β Suppresses Gastrin via Primary Cilia and Induces Antral Hyperplasia.
12/2017	Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.
7/2017	Pathophysiology of Gastric NETs: Role of Gastrin and Menin.
1/2017	Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
9/2012	Conditional deletion of menin results in antral G cell hyperplasia and hypergastrinemia.
7/2012	IFNγ contributes to the development of gastric epithelial cell metaplasia in Huntingtin interacting protein 1 related (Hip1r)-deficient mice.
1/2012	Inflammation and Gli2 suppress gastrin gene expression in a murine model of antral hyperplasia.
12/2010	Histamine 3 receptor activation mediates inhibition of acid secretion during Helicobacter-induced gastritis.
12/2010	Intracellular calcium release and protein kinase C activation stimulate sonic hedgehog gene expression during gastric acid secretion.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juanita L Merchant Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 06/2003
17	Inflammation (Inflammations) 01/2022 - 01/2002
13	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2005
10	Metaplasia 01/2022 - 02/2005
9	Infections 01/2022 - 10/2003
9	Gastritis 12/2010 - 01/2002
7	Hyperplasia 01/2022 - 11/2008
6	Helicobacter Infections 01/2022 - 10/2003
6	Carcinogenesis 01/2022 - 05/2008
6	Atrophy 01/2021 - 03/2005
5	Achlorhydria (Hypochlorhydria) 12/2010 - 01/2002
4	Atrophic Gastritis 01/2017 - 03/2005
4	Adenocarcinoma 01/2017 - 03/2005
3	Carcinoid Tumor (Carcinoid) 01/2022 - 01/2017
3	Gastrinoma 12/2017 - 10/2008
3	Multiple Endocrine Neoplasia Type 1 12/2017 - 10/2008
3	Bacterial Infections (Bacterial Infection) 11/2013 - 05/2004
2	Polyps 11/2017 - 12/2012
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2017 - 02/2012
2	Hepatocellular Carcinoma (Hepatoma) 12/2013 - 09/2009
2	Colitis 12/2012 - 01/2006
2	Pancreatitis 10/2012 - 08/2007
2	Hypertrophy 07/2012 - 05/2005
2	Colonic Neoplasms (Colon Cancer) 12/2007 - 09/2006
1	Glioma (Gliomas) 02/2019
1	Cholangiocarcinoma 02/2019
1	Aneurysm (Aneurysms) 01/2019
1	Abdominal Aortic Aneurysm 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2017
1	Stomach Diseases 01/2017
1	Neuroendocrine Carcinoma 01/2017
1	Mucolipidoses (Sialidosis) 01/2017
1	Weight Gain 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Dysbiosis 12/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2015
1	Carcinoma (Carcinomatosis) 02/2014

Drug/Important Bio-Agent (IBA)

20	GastrinsIBA 01/2022 - 01/2002
16	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
10	CytokinesIBA 01/2021 - 10/2003
8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 01/2002
7	AntralIBA 01/2021 - 03/2005
6	AcidsIBA 01/2022 - 04/2003
5	spasmolytic polypeptideIBA 01/2022 - 07/2012
5	LigandsIBA 03/2017 - 07/2010
5	Omeprazole (Prilosec)FDA LinkGeneric 01/2017 - 01/2002
4	Messenger RNA (mRNA)IBA 10/2020 - 12/2010
4	Transcription Factors (Transcription Factor)IBA 12/2016 - 04/2006
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 01/2012
3	Butyrates (Butyrate)IBA 11/2017 - 12/2012
3	villinIBA 01/2017 - 02/2005
3	Phenobarbital (Luminal)FDA Link 02/2014 - 07/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2005 - 01/2002
2	Proton Pump InhibitorsIBA 01/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2017
2	B7-H1 AntigenIBA 12/2021 - 10/2021
2	RNA (Ribonucleic Acid)IBA 10/2020 - 03/2016
2	InterleukinsIBA 02/2019 - 02/2010
2	Histones (Histone)IBA 01/2019 - 12/2013
2	ChromatinIBA 01/2019 - 01/2016
2	Hormones (Hormone)IBA 12/2017 - 10/2008
2	CyclinsIBA 07/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 08/2007
2	CateninsIBA 12/2016 - 12/2012
2	Dual OxidasesIBA 12/2015 - 11/2013
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2015 - 11/2013
2	Patched ReceptorsIBA 02/2014 - 07/2010
2	EnzymesIBA 12/2013 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 08/2007
2	Histone Deacetylase InhibitorsIBA 12/2007 - 09/2006
2	Peptides (Polypeptides)IBA 11/2007 - 05/2004
2	Type IV Secretion SystemsIBA 08/2007 - 05/2005
2	Interleukin-4 (Interleukin 4)IBA 03/2006 - 10/2003
2	Octreotide (Sandostatin)FDA LinkGeneric 02/2005 - 10/2003
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Toll-Like Receptor 9IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 12/2021
1	Epidermal Growth Factor (EGF)IBA 12/2021
1	MicroRNAs (MicroRNA)IBA 10/2020
1	Interleukin-33IBA 02/2019
1	Neurofibromin 1 (Neurofibromin)IBA 01/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2017
1	Volatile Fatty AcidsIBA 11/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2017
1	AminesIBA 07/2017
1	YM 022IBA 01/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Cholecystokinin B ReceptorIBA 01/2017
1	Cyclic NucleotidesIBA 01/2017
1	ParaffinIBA 01/2017
1	Cre recombinaseIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 03/2016
1	CarcinogensIBA 01/2016
1	MethyltransferasesIBA 12/2013

Therapy/Procedure

2	Immunotherapy 12/2021 - 10/2021
2	Therapeutics 01/2013 - 02/2005
2	Drug Therapy (Chemotherapy) 01/2012 - 06/2003
1	Transplantation 10/2021